Hepatic Carcinoma: Clinical Trials

4 trials for Hepatic Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Unknown 3, Completed 1
Phase 22Unknown 2

Follow Hepatic Carcinoma: new trials by email Literature Review of Hepatic Carcinoma trials Research Report on Hepatic Carcinoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs
Tumor infiltrating lymphocyte - Hepatic Carcinoma
Phase 1 / Phase 2UnknownCAR-T (Shanghai) Cell Biotechnology Co., Ltd.402020-08-262020-09-04
Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.
Sintilimab, Microwave Ablation, TACE - Hepatic Carcinoma
Phase 1UnknownShanghai Zhongshan Hospital452020-01-012024-08-01
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
CAR-T cell immunotherapy - Colon Cancer, Esophageal Carcinoma
Phase 1 / Phase 2UnknownFirst Affiliated Hospital of Chengdu Medical College602017-01-012017-01-06
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
H3B-6527 - Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma
Phase 1CompletedH3 Biomedicine Inc.1282016-12-282023-11-13

Narrower conditions

Carcinoma, Hepatocellular (4)  ·  Colonic Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Stomach Neoplasms (1)

Broader conditions

Adenocarcinoma (4)  ·  Carcinoma (4)  ·  Digestive System Diseases (4)  ·  Digestive System Neoplasms (4)  ·  Liver Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Liver Neoplasms (3)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Esophageal Diseases (1)

Interventions

H3B-6527 (1)  ·  Immunotherapy, Adoptive (1)  ·  sintilimab (1)

Sponsors

CAR-T (Shanghai) Cell Biotechnology Co., Ltd. (1)  ·  First Affiliated Hospital of Chengdu Medical College (1)  ·  H3 Biomedicine Inc. (1)  ·  Shanghai Zhongshan Hospital (1)

Countries

China (3)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  Russia (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Xiao-an Li, PhD (1)

NIH funding

2016 (1)